Renal interstitial fibrosis (RIF): II. Ultrasound follow up study of single uranyl nitrate administration causing renal dysfunction in rats--comparison with histologic and functional renal parameters.
A single administration of uranyl nitrate (UN; 0.5 mg/100 g b. wt. i.p.) to adult female Wistar rats reliably induces renal interstitial fibrosis (RIF) providing an experimental model to investigate therapeutic strategies. It was the aim of this study to further characterise a rat model of UN induced RIF which we have studied previously (Appenroth et al. 2001) by the comparison of functional parameters with ultrasonographic examination over a period of 30 weeks after injury. In the acute phase after UN administration (between days 2 and 17) signs of inflammation (increase in renal blood flow, swelling of renal cortex, enlargement of renal pelvis) could be detected by ultrasound. After four weeks UN led to functional changes (decreased creatinine clearance, increased urinary protein excretion and increased OH-proline concentration in renal tissue). In vitro, the accumulation of p-aminohippurate and the gluconeogenesis were reduced. In accordance with the functional changes, distinct ultrasonographic abnormalities could be seen between weeks 10 and 30 after UN with regard to changes in kidney size and shape, reduced renal perfusion and enlargement of renal pelvis. The sensitivity of ultrasonography in small laboratory animals is limited and most useful for follow-up studies of acute renal changes after administration of nephrotoxins. Ultrasonography can not be recommended for non-invasive screening of the progression of chronic renal failure.
Fleck
Marlies
M
Institute of Diagnostic and Interventional Radiology, Friedrich Schiller University Jena, Germany.
Appenroth
Dorothea
D
Malich
Ansgar
A
Stein
Günter
G
Fleck
Christian
C
D000208:Acute Disease; D000818:Animals; D003404:Creatinine / Q000652:urine; D004195:Disease Models, Animal; D005260:Female; D005355:Fibrosis; D005500:Follow-Up Studies; D005943:Gluconeogenesis; D006909:Hydroxyproline / Q000378:metabolism; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D007668:Kidney / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000473:pathology; D007672:Kidney Cortex / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D009395:Nephritis, Interstitial / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D018616:Ultrasonography, Doppler, Duplex; D014502:Uranyl Nitrate / Q000008:administration & dosage / Q000633:toxicity*; D010130:p-Aminohippuric Acid / Q000378:metabolism
D014502:Uranyl Nitrate; D003404:Creatinine; D006909:Hydroxyproline; D010130:p-Aminohippuric Acid